2022
Cerebral hypoperfusion after nimodipine administration is associated with worse functional outcomes in subarachnoid hemorrhage patients (P6-7.001)
Bartolome D, Begunova Y, Prasad A, Soto A, Kobsa J, Top I, Quispe-Orozco D, Farooqui M, Zevallos C, Kim J, Gilmore E, Beekman R, De Havenon A, Matouk C, Sheth K, Ortega-Gutiérrez S, Petersen N. Cerebral hypoperfusion after nimodipine administration is associated with worse functional outcomes in subarachnoid hemorrhage patients (P6-7.001). Neurology 2022, 98 DOI: 10.1212/wnl.98.18_supplement.3609.Peer-Reviewed Original Research
2012
Acute Effects of Nimodipine on Cerebral Vasculature and Brain Metabolism in High Grade Subarachnoid Hemorrhage Patients
Choi HA, Ko SB, Chen H, Gilmore E, Carpenter AM, Lee D, Claassen J, Mayer SA, Schmidt JM, Lee K, Connelly ES, Paik M, Badjatia N. Acute Effects of Nimodipine on Cerebral Vasculature and Brain Metabolism in High Grade Subarachnoid Hemorrhage Patients. Neurocritical Care 2012, 16: 363-367. PMID: 22262041, DOI: 10.1007/s12028-012-9670-8.Peer-Reviewed Original ResearchConceptsPoor-grade subarachnoid hemorrhageOral nimodipineSubarachnoid hemorrhageMmHg decreasePoor-grade SAH patientsDoses of nimodipineAdministration of nimodipineAneurysmal subarachnoid hemorrhageSubarachnoid hemorrhage patientsRoutine clinical careAcute PhysiologicAdequate CBFNimodipine administrationOnly medicationHemorrhage patientsMultimodality monitoringSAH patientsVasopressor medicationsBrain metabolismAcute effectsObservational studyMetabolic effectsCerebral vasculatureClinical careNimodipine